使用叶酸结合的海绵状ZIF-8纳米颗粒进行向癌症治疗:一篇综述
Mahsa Akbari Oryani1, Shamim Nosrati2, Hossein Javid3,4,5
1Department of Pathology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Naunyn-Schmiedeberg's archives of pharmacology
|September 16, 2023
概括
焦化物伊米达酸框架-8 (ZIF-8) 纳米颗粒由于其稳定性和pH响应的药物释放,对向癌症治疗具有前途. 叶酸结合增强了ZIF-8向癌细胞的传递,提高了治疗效率.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 化物伊米达酸框架-8 (ZIF-8) 纳米颗粒对药物输送具有有利的特性,包括高表面积,毛孔容量,负载能力和生理稳定性.
- ZIF-8的可调节结构允许使用向配体进行功能化,增强对癌细胞的特异性并提高化疗疗效.
- 由于ZIF-8的pH反应性,使药物在酸性瘤微环境中释放得更容易,而在生理条件下的稳定性确保了循环过程中的完整性.
研究的目的:
- 审查ZIF-8纳米颗粒作为癌症治疗药物输送系统的潜力.
- 突出ZIF-8功能化的优点,特别是叶酸,用于向癌症治疗.
- 讨论ZIF-8介导药物递送的机制,包括向,释放和减少副作用.
主要方法:
- ZIF-8纳米颗粒的功能化与向连接体.
- 研究ZIF-8的pH响应药物释放特征.
- 评估叶酸结合的ZIF-8通过叶酸受体对癌细胞进行向输送.
主要成果:
- ZIF-8纳米粒子表现出卓越的稳定性和药物加载能力.
- 叶酸的功能化使得向性结合癌细胞能够过度表达叶酸受体.
- 证实ZIF-8的pH反应性药物释放,促进局部治疗作用.
结论:
- 叶酸结合的ZIF-8代表了针对性癌症治疗的有希望的策略,增强药物输送并最大限度地减少非目标效应.
- ZIF-8的独特特性,包括其可调节的结构和pH敏感性,使其成为开发先进癌症治疗的多功能平台.
- 对基于ZIF-8的药物输送系统的进一步研究具有显著的潜力,可以改善瘤学患者的治疗结果.
更多相关视频
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.7K
05:55Synthesis and Characterization of Placental Chondroitin Sulfate A plCSA-Targeting Lipid-Polymer Nanoparticles
Published on: September 18, 2018
8.8K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
